JPMorgan Chase & Co. reiterated their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a research report released on Monday morning, Borsen Zeitung reports. JPMorgan Chase & Co. currently has a GBX 6,500 ($85.50) target price on the stock.
A number of other research firms have also recently issued reports on RB. BNP Paribas raised Reckitt Benckiser Group to an outperform rating and reduced their price objective for the company from GBX 6,500 ($85.50) to GBX 6,300 ($82.87) in a research report on Wednesday, March 18th. Goldman Sachs Group lifted their price objective on Reckitt Benckiser Group from GBX 5,800 ($76.30) to GBX 6,000 ($78.93) and gave the company a neutral rating in a research report on Tuesday, March 17th. HSBC reduced their price objective on Reckitt Benckiser Group from GBX 7,100 ($93.40) to GBX 6,800 ($89.45) and set a buy rating for the company in a research report on Wednesday, March 18th. UBS Group reduced their price objective on Reckitt Benckiser Group from GBX 6,100 ($80.24) to GBX 5,700 ($74.98) and set a neutral rating for the company in a research report on Wednesday, March 4th. Finally, Citigroup reissued a buy rating on shares of Reckitt Benckiser Group in a research report on Wednesday, March 11th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and an average target price of GBX 6,386.58 ($84.01).
RB opened at GBX 5,970 ($78.53) on Monday. The stock has a market cap of $42.38 billion and a price-to-earnings ratio of -11.49. Reckitt Benckiser Group has a 1 year low of GBX 5,130 ($67.48) and a 1 year high of GBX 8,191.30 ($107.75). The company has a current ratio of 0.56, a quick ratio of 0.41 and a debt-to-equity ratio of 130.80. The stock has a fifty day moving average price of GBX 6,049.70 and a 200 day moving average price of GBX 6,093.88.
The business also recently disclosed a dividend, which will be paid on Thursday, May 28th. Shareholders of record on Thursday, April 16th will be issued a dividend of GBX 101.60 ($1.34) per share. This represents a yield of 1.64%. This is an increase from Reckitt Benckiser Group’s previous dividend of $73.00. The ex-dividend date of this dividend is Thursday, April 16th. Reckitt Benckiser Group’s payout ratio is presently -0.39%.
In related news, insider Laxman Narasimhan acquired 17,241 shares of the firm’s stock in a transaction on Tuesday, March 3rd. The shares were bought at an average cost of GBX 5,800 ($76.30) per share, with a total value of £999,978 ($1,315,414.36).
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Article: How is diluted EPS different from basic EPS?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.